NUPCO CEO to Asharq Al-Awsat: We Helped Raise Efficiency In Health Sector Spending

NUPCO CEO Fahad Al-Shebel said that the company is always seeking to offer health services “at the right time, the right place at the right price as well.” (Asharq Al-Awsat)
NUPCO CEO Fahad Al-Shebel said that the company is always seeking to offer health services “at the right time, the right place at the right price as well.” (Asharq Al-Awsat)
TT

NUPCO CEO to Asharq Al-Awsat: We Helped Raise Efficiency In Health Sector Spending

NUPCO CEO Fahad Al-Shebel said that the company is always seeking to offer health services “at the right time, the right place at the right price as well.” (Asharq Al-Awsat)
NUPCO CEO Fahad Al-Shebel said that the company is always seeking to offer health services “at the right time, the right place at the right price as well.” (Asharq Al-Awsat)

The CEO of Saudi Arabia's National Unified Procurement Company (NUPCO), Fahad Al-Shebel, said the entity has helped enhance spending efficiency over the past years, making it among the contributors to the Saudi Vision 2030.

In an interview with Asharq Al-Awsat, Al-Shebel highlighted NUPCO’s strategy in providing products and health services to its customers on time and at the right price.

NUPCO was established in 2008 and began operating in 2009, with a main objective of raising spending efficiency in purchasing medicines, devices and medical supplies, Al-Shebel said.

It is the Kingdom’s largest provider of standardized procurement services to government agencies working in the healthcare sector.

“During the past years, the company managed to enhance the efficiency of spending significantly and contributed to raising the level of quality of service provided to health authorities. We are proud to be part of the implementation of the Kingdom’s Vision 2030 in terms of spending efficiency,” he underlined.

“The company also aims to improve the quality of life of citizens and residents in the country, by providing better and high-quality health services.”

Stressing that the company’s strategy was to focus on providing unified procurement services to customers in a good and fast way and to ensure the availability of the products they need, Al-Shebel said that NUPCO was always seeking to offer health services “at the right time, the right place at the right price as well.”

The company also provides supply chain services, which include storing and delivering products to hospitals and health centers.

Al-Shebel noted that NUPCO is an independent company established by royal order and operates in complete independence from the Ministry of Health.

“The Health Ministry is one of NUPCO’s most important strategic clients, as annual government purchases represent the largest proportion of the company’s work,” he remarked.

The entity is currently focusing on the public sector and its strategic plan includes a better expansion in 2022.

In this regard, Al-Shebel explained that the services cover the ministries of Health, Defense and Interior, the National Guard, specialized hospitals and medical cities, as well as all government health service providers.

The company’s performance concerning government purchases was good during 2019, according to the CEO, who noted that NUPCO’s purchases exceeded 62% of all government procurements.

“The number of beneficiaries of our services has reached 54, and there is a great expansion. During the past year, we provided our services to new clients from the government health sector,” he said.

Al-Shebel revealed that existing mechanisms relied on the development of standardized evidence and clear specifications that include accurate information and reference prices, to assist in the negotiation process with pharmaceutical or medical supplies companies.

“Building unified evidence is one of the most important mechanisms that we follow. It helps with purchasing certain products in large quantities, rather than buying separate products, which contributes to supporting negotiations with relevant companies and achieving an abundance of spending,” he explained.

Asked about the proportion of locally-made medicine in the overall purchased products, Al-Shebel said: “The percentage of local products in 2019 reached more than 23% of the total value of medicines, devices, and medical supplies.”

“We have local factories that we are proud of, and in the coming years we hope to further enhance local content,” he added.

Regarding NUPCO’s main challenges, the CEO said: “Time is the biggest challenge in supply chains, and we are working to get medicine and medical supplies to the right place in record time.”

“Raising the availability of medicine in Saudi Arabia and ensuring that the required products are available at the required moment is another goal that we are seeking to achieve,” he noted, adding that a third challenge was represented in making drug prices in the Kingdom among the lowest.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.